Liquidia Corp — Director's Dealing 2021

Jan 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Liquidia Corp (LQDA)
CIK: 0001819576
Period of Report: 2021-01-19

Reporting Person: Moomaw Scott (SVP, Commercial)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-19	Employee Stock Option (right to buy)	$2.97	A	15300	Acquired	2031-01-19	Common Stock (15300)	Direct
2021-01-19	Performance Stock Units	$0	A	7650	Acquired		Common Stock (7650)	Direct

Footnotes

F1: The option vests in equal monthly installments over a four-year period, becoming fully vested on January 19, 2025.

F2: The performance stock units (PSUs) vest in full upon tentative approval by the U.S. Food and Drug Administration of the New Drug Application for LIQ861. Each PSU represents a contingent right to receive one share of common stock of the issuer.